insight

patient

Xeris Biopharma Holdings Inc

manipulation

$XERS  This stock has become totally distorted by Wall Street manipulators!

In fact its just market manipulation by  shorts and rich assholes who use stocks like slot machines.

$XERS This stock is heavily MANIPULATED by a &quot;Gang of Shortsellers&quot; and has nothing to do with a fair market price!

It is so obvious this is being systematically walked down (manipulated) and has nothing to do with the Company itself, products, or the overall market.

Just goes to show how badly manipulated this is.

The manipulation of these criminals is unbelievable.

price

This Share Price is still 
 
Crazy  
 
Stupid  
 
Low. Cheers!

$XERS  This share price is crazy stupid low.

You’d think Paul would have some shame being below their price.

What is most disappointing about XERS, except for the collapse in stock price, is the failure of management to do much of anything to encourage retail or institutional investors to continue to have the confidence in management of the company or its future.

I think price targets are fake… there compensated to make targets IMO.

suck

Unfortunately, the mkt sucks now and that’s reflected in sp.

The whole market sucks and this has been unjustly hammered.

$XERS this is so fucked up its unbelievable.

Invested a lot of money , and realizing we are fucked.

market

What a crappy market! Hopefully next week will be better:)

$XERS A bad market must admit it is really a bad day.

$XERS A 10+ cent drop when you only have 14 of those until 0 ahead of all that gobbledygook fundamental longs are spouting is not a great sign of market confidence.

$XERS market on a year and this lame duck is flat or sinking

but unfortunately, in this market, not cheap either, and even less an outright buy without a very very strong conviction.

Market hinting something is terribly wrong with this company.

revenue

$XERS High risk is an understatement with XERS, weak drug lineup, weak pipeline, revenue grow slowing, cash burn increasing and worse than weak management should tell you to stay away.

Nothing positive, revenue continues to slow, spending increasing, generics coming, recorlev under performing and most important, incompetent management! !

Personally, I think this is very conservative, and comes in below the Strongbridge &quot;Low Case&quot; from page 87 of the merger prospectus because it comes out to $172M annual revenue in 2023 compared to $216M revenue on the prospectus.

Revenues are slowing, expenses are increasing, tech is marginal, patents will be expiring, pipeline is horrible and management is horrible.

but also very disappointing that my EV charger stocks have $Billion mkt caps with less than $50M revenue and years from cash flow positive and yet.

Not only are the current drugs low revenue producers and the pipeline is horrible.

.WS not impressed with 3 low revenue drugs and weak pipeline.

With breakeven insight and possibly 1-2 collaborations coming to fruition in 12 months, sales exploding in Recorlev and GVoke.. yikes 😳 would be stupid and irresponsible to be a short.

$XERS On Gvoke, &quot;better than expected growth&quot;:   
&quot;Opportunity remains huge, and you don&#39;t have to find patients.

QoQ growth would still increase by ~40% with no new patients.

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

Two other drugs, each growing revenue steadily.

That said, I fully expect continuing  script and revenue growth, upcoming cashflow breakeven and some nice juicy licensing deals to resolve that in the months ahead.

Two (2) other drugs, each growing revenue steadily.

There is so much good news here, growing revenue, a stable base, conservative management, and connections to big pharma.

drug

A levothyroxine formulation that looks positive (most commonly prescribed drug) A full proven technology platform to deliver hard to administer drugs by a simple injection.

We have other amazing drugs, Recorlev, Gvoke and more including some drugs yet to be approved.

product

$XERS their primary product increases 9% week to week sales with an overall trend that&#39;s incredible.

$XERS I like their products and the inject opportunity with Horizon Tepezza is huge I wish they weren&#39;t acquired so they can keep a focus on that.

Earnings are growing and there could be great news any day from a variety of sources, whether a collab exercise of option, new product collab, royalty pmt, etc.

More important is that they grow Recorlev&#39;s revenue at high(er) speed, and continue to gain market share with Gvoke without product price drop.

Revenue exploding on the upside with
their 4 products.

Even if they have more short term gains coming soon, we know the Gvoke product will gain share back due to the more pleasant experience. Patience.

Gvoke is the best and easiest product out there.

Products have been approved and much more is coming, wait and relax.

For a tiny company like xeris to go toe to toe with lilly and grow share shows they have the best product.

$XERS Truly so strange, everything Xeris had in its programme has been met, briefly 3 FDA approved products, collaborations with major pharmacies and much, much more.

Novo Integrated Sciences Inc

crypto

$NVOS It would have been better to throw my money into crypto garbage than into this fire dumpster.

fire

This thing is not looking good, what was with that huge volume, yesterday, to end up being a complete dumpster fire.

investor

.slut
You are just a horrible investor 🤣🤣🤣

An increase in short sale volume suggests bearish (negative) sentiment among investors.

I hate the kind of investors stocks like this one attract.

$NVOS  just stop with the bs you are misleading people in a suggestive manner you gas lighting pos

I would like to return the bags for my money to the POS MGNT.

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

$NVOS MAKE SENSE GO BUY BANK STOCK GO HIGHER THAN THIS SHIT.

$NVOS great buy here at these levels. ⏳🤑

service

Stock price will soar on this news alone and will go even higher with announcement of 180 day extension for Nasdaq compliance and positive earnings.

They are going through the stratosphere and the price just keeps going down.

$NVOS 
Added another good chunk at this price

Enjoy with your family and friends, and dont check the price every minut🤎

$NVOS thank you for this $.1211 price

Added 10k more….I’m buying every dip

Still very successful with holding the price down,

$NVOS Price movement looking very bullish at the moment.

Provention Bio Inc

position

but would never tell us his position, which is probably short with Puts.

executive

to illustrate what a pathetic POS the ceo of $omer is, just compare him to $PRVB  
both receive BTD around same time.

stop

Go back to business school and stop with the  trash talk.

level

but sometimes when everybody was having a blast, we forgot to check his levels, which he also forgot to check.

I can still remember his zombified face(which is basically the face of a person leaving this place) while he said, that he forgot to check the levels.

in just one year, for a patient, 1,460 finger sticks to check blood glucose levels, around 1,100 insulin injections, and experiencing an average of 127 episodes of hypoglycemia.

Diabetes is no joke my father in law has it and its really disturbing once it reaches a level that affects yorkur day to day

volume

$prvb volume is extraordinarily and no support anywhere.

$PRVB they are keeping the volume low with the bullshit algos

Hats off to you with all the good insight.

I have been sharing snippets of his posts here on ST occasionally and find his insights extremely helpful to navigating this wild market. https://youtu.be/AY1nlZMAiXI

Pretty good place to be with  LUPKYNIS being the only treatment for lupus nephritis, in a multibillion dollar marketspace, with M&amp;A heating up.

Patients and their family now have hope, hope for a positive outcome with treatment with  TZIELD,  and hope that other treatments will be coming along to further improve the disease.

first effective diabetes treatment in a while

I&#39;m overjoyed for the T1D community, and for all the patient long term investors here.

$PRVB This is good news for the patients;

This is a major milestone and validates the belief in the ability of this drug to improve patient lives.

$PRVB great to see major approval for diabetes congrats to all the patients and shareholders

Congrats all, and I’m so excited for the patients who will benefit from this.

$PRVB 

Finally, happy to see this therapy put to use for at risk patients!

bull

$PRVB is currently showing a bull flag pattern!

$PRVB congrats bulls 🏆 

I added half of my profits to $CUE its gonna be next BO/merger imo.

$PRVB Congrats to the long suffering bulls and investors here.

congrats to all my long bulls and especially those in rhe TD1 community.

$PRVB congrats to all the long term bulls!!!

$PRVB Congratulations to you bulls here!.

approval

gets a drug approved and immediately rewards shareholders!!!

$PRVB 8.60 to 8.80 has been good support since approval.

If that gets approved its 10.000 times better than Provention Bio.

Great to see the FDA approval, as well as $SNY commitment.

$PRVB  While reaching this milestone of approval has been inspirational, it is now the aspirational goal of population screening which is at the forefront.

It works, there is a need for it, there is insurance buy in on it, there is a global sales team, there is further label expansion and approvals in the future, and there are additional drugs in the pipeline from this company that show the same promise.

PRVB is in a MUCH better financial situation now with FDA approval giving them a multi-billion USD asset (Teplizumab)  which they can get conventional financing from A BANK!!

$PRVB Interesting they received approval which is good.

$PRVB good that they have got an approval.

the TAM is huge for these 2 drugs, and I read the comments from BIVI&#39;s CEO during his presentation at Oppenheimer recently - I thought were very exciting and positive.

$PRVB Provention Bio’s contributions to the field of medicine are commendable, and the company has an impressive pipeline of innovative drugs.

But never lost the faith on it and waiting faithfully well rewarded especially for a drug that well needed and one of kind in the field.

This is HUGE NEWS.. Stop looking at $SNY &amp; start concentrating on the potential this LIFE CHANGING drug will have on people!

This has potential to be a miracle drug that can save many.

Is a good important drug with a huge Market.

$PRVB  
 
Guys, it&#39;s a wonderful drug

Top Stocks matching your search for "insights patients"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Feb, 28, 2023

NVOS

Novo Integrated Sciences Inc

6.11%

$0.13 - $0.14

PRVB

Provention Bio Inc

154.85%

$9.39 - $23.93

Mar, 13, 2023

Dec, 4, 2022

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Feb, 28, 2023

NVOS

Novo Integrated Sciences Inc

6.11%

$0.13 - $0.14

PRVB

Provention Bio Inc

154.85%

$9.39 - $23.93

Mar, 13, 2023

Dec, 4, 2022